U.S. FDA Approves ZubsolvĀ® for the Maintenance Treatment of Opioid Dependence NEW YORK, July 5, 2013 /PRNewswire/ -- Orexo U.S., Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Zubsolv (buprenorphine and naloxone) sublingual tablets ...
July 5, 2013 - PR Newswire via Yahoo! Finance